Depression is one of the most widely misunderstood psychological conditions in the modern world. A lot of people simply assume that it’s about people feeling said. Unfortunately, it goes a lot deeper than that since it can mean a constant, crippling absence of any sensation related to happiness or satisfaction. In an effort to curtail the damage that this condition can do, a new app equipped with an artificial intelligence is being tested right now.
One of the most effective treatments for depression is talking to psychotherapists who will work with patients through their emotional distress. However, talking about depression is not easy and plenty of people often avoid it altogether. The new app called Woebot could provide an effective bridge in such situations by giving patients an avenue for a conversation with something that’s not human, Business Insider reports.
The app was created by Stanford University clinical psychologist Alison Darcy. According to her, Woebot was based on the treatment cognitive-behavioral therapy (CBT), which is intended to measure patient reactions to challenging scenarios. Darcy also notes that while Woebot can’t replace human therapists, it can still pave the way to recovery.
“What we haven’t done a good job of in [therapy] is give people an array of options — what about the people who aren’t ready to talk to another person?” Darcy said. “This is part of the idea of meeting people where they’re at.”
As to how effective the chatbot can even be, Darcy and her team published a study that showed a marked improvement in patients suffering from depression while interacting with Woebot. Naturally, more research is needed in order to make any kind of concrete conclusion with regards to using AI-powered chatbots as official psychological treatment tools.
However, this development does signal an encouraging direction in which therapists can go. The rate of suicide among teens and young adults has seen an alarming rise over recent years. This technology could pave the way to substantially reducing that.


Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
DeepSeek to Raise AI API Prices as Demand for New Models Surges 



